IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Senores Pharmaceuticals IPO is a Book building listing on BSE,NSE exchange, with an ipo size of ₹ 582.11 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Ambit , Equirus Capital , Nuvama Wealth Management are the merchant bankers of Senores Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th July 2024.
Senores Pharmaceuticals IPO posted revenues of ₹ 366.70 crores and PAT of ₹ 47.88 crores in FY25 on annualised basis.
Revenue:
₹ 362.00 Cr.
EBITDA Margin:
[●]
% 
Net Worth: ₹ 319.00 Cr.
Market Capitalisation:
₹ 1350.70 Cr.
P/E:
28.21 times
P/BV: 1.50 times
EV/EBITDA: [●]
Financial results of Senores Pharmaceuticals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-24 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 678.00 | 621.80 | 131.00 | 59.10 | |
| Net Worth | 319.00 | 231.70 | 45.40 | 36.50 | |
| Total Debt | 241.90 | 248.30 | 60.70 | 14.10 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
181.00
362.00 |
214.50 | 35.30 | 14.10 | |
EBITDA
EBITDA on annualised basis |
[●]
[●] |
[●] | [●] | [●] | |
PAT
PAT on annualised basis |
23.90
47.80 |
32.70 | 8.40 | 0.90 | |
Senores Pharmaceuticals IPO PAT Margin is 13.20 % , ROCE (Return on Capital Employed) is 7.59 % as per latest financial. The below table shows Senores Pharmaceuticals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | [●] | [●] | [●] | [●] |
| PAT Margin (%) | 13.20 | 15.24 | 23.80 | 6.38 |
| EPS (₹) | 7.20 | 13.67 | 8.87 | 1.81 |
| ROE (%) | 7.49 | 14.11 | 18.50 | 2.47 |
| ROCE (%) | 7.59 | 11.73 | 18.56 | 5.38 |
| ROA (%) | 3.53 | 5.26 | 6.41 | 1.52 |
| Debt to Equity | 0.76 | 1.07 | 1.34 | 0.39 |
The market Capitalisation of Senores Pharmaceuticals IPO is ₹ 1350.70 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Senores Pharmaceuticals IPO prospectus highlights an Return on Equity (ROE) of 7.49 % , Return on Assets (ROA) of 3.53 %, and an EBITDA Margin of [●] %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Senores Pharmaceuticals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Senores Pharmaceuticals IPO is ₹ 1350.70 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Senores Pharmaceuticals IPO has a Price-to-Earnings (PE) ratio of 28.21 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Senores Pharmaceuticals IPO reported revenue of ₹ 366.70 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Senores Pharmaceuticals IPO provide insights into sales growth, market demand, and business scalability.
Senores Pharmaceuticals recorded an EBITDA of [●], reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Senores Pharmaceuticals Profit After Tax (PAT) is ₹ 47.80 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 362.00 Cr.
EBITDA Margin:
[●]
%
Net Worth: ₹ 319.00 Cr.
Market Capitalisation:
₹ 1350.70 Cr.
P/E:
28.21 times
P/BV: 1.50 times
EV/EBITDA: [●]
Senores Pharmaceuticals operates in Pharmaceutical and Develops And Manufactures A Range Of Pharmaceutical Products Primarily For The Regulated Markets. The Issue is listed on BSE,NSE in Dec, 2024. Senores Pharmaceuticals IPO size was 582.11 with Issue price of 391.00 .
Merchant Banker(s) of Senores Pharmaceuticals IPO: Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited
Senores Pharmaceuticals IPO subscription was 97.86 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Senores Pharmaceuticals IPO listed at a listing price of 609.00 against the offer price of 391.00.
The current market price of Senores Pharmaceuticals is 573.00.
Why Us?
